These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 39118083)
1. 5-Fluorouracil resistance due to sphingosine kinase 2 overexpression in colorectal cancer is associated with myeloid-derived suppressor cell-mediated immunosuppressive effects. Li X; Chen Y; Liang Y; Shi W BMC Cancer; 2024 Aug; 24(1):983. PubMed ID: 39118083 [TBL] [Abstract][Full Text] [Related]
2. SphK2 confers 5-fluorouracil resistance to colorectal cancer via upregulating H3K56ac-mediated DPD expression. Zhang YH; Shi WN; Wu SH; Miao RR; Sun SY; Luo DD; Wan SB; Guo ZK; Wang WY; Yu XF; Cui SX; Qu XJ Oncogene; 2020 Jul; 39(29):5214-5227. PubMed ID: 32546724 [TBL] [Abstract][Full Text] [Related]
3. Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo. Xun C; Chen MB; Qi L; Tie-Ning Z; Peng X; Ning L; Zhi-Xiao C; Li-Wei W J Exp Clin Cancer Res; 2015 Sep; 34(1):94. PubMed ID: 26337959 [TBL] [Abstract][Full Text] [Related]
4. Quinacrine-Mediated Inhibition of Nrf2 Reverses Hypoxia-Induced 5-Fluorouracil Resistance in Colorectal Cancer. Kim HG; Kim CW; Lee DH; Lee JS; Oh ET; Park HJ Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491980 [TBL] [Abstract][Full Text] [Related]
5. PFKP is upregulated in 5-fluorouracil-resistant patients and suppresses the antitumor activity of 5-fluorouracil in colorectal cancer Deng L; Zhao Y; Liu W J Chemother; 2024 Sep; 36(5):422-434. PubMed ID: 38044588 [TBL] [Abstract][Full Text] [Related]
6. Syndecan-2, negatively regulated by miR-20b-5p, contributes to 5-fluorouracil resistance of colorectal cancer cells via the JNK/ERK signaling pathway. Hua R; Zhang Y; Yan X; Tang D; Li X; Ni Q; Wang D; Zhu J Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1547-1557. PubMed ID: 34596215 [TBL] [Abstract][Full Text] [Related]
7. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer. Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X Front Immunol; 2022; 13():887048. PubMed ID: 35784334 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer. Xu F; Ye ML; Zhang YP; Li WJ; Li MT; Wang HZ; Qiu X; Xu Y; Yin JW; Hu Q; Wei WH; Chang Y; Liu L; Zhao Q Cancer Sci; 2020 May; 111(5):1528-1541. PubMed ID: 32073706 [TBL] [Abstract][Full Text] [Related]
9. RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells. Soong RS; Anchoori RK; Yang B; Yang A; Tseng SH; He L; Tsai YC; Roden RB; Hung CF Oncotarget; 2016 Oct; 7(42):68489-68502. PubMed ID: 27655678 [TBL] [Abstract][Full Text] [Related]
10. TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages. Liu Z; Xie Y; Xiong Y; Liu S; Qiu C; Zhu Z; Mao H; Yu M; Wang X Cancer Lett; 2020 Jan; 469():173-185. PubMed ID: 31629935 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of NLRP3 inflammasome activation in myeloid-derived suppressor cells by andrographolide sulfonate contributes to 5-FU sensitization in mice. Xu L; Cai P; Li X; Wu X; Gao J; Liu W; Yang J; Xu Q; Guo W; Gu Y Toxicol Appl Pharmacol; 2021 Oct; 428():115672. PubMed ID: 34391754 [TBL] [Abstract][Full Text] [Related]
12. Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice. Khosravianfar N; Hadjati J; Namdar A; Boghozian R; Hafezi M; Ashourpour M; Kheshtchin N; Banitalebi M; Mirzaei R; Razavi SA Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):47-55. PubMed ID: 29512369 [TBL] [Abstract][Full Text] [Related]
13. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells. Li X; Ma Y; Wu J; Ni M; Chen A; Zhou Y; Dai W; Chen Z; Jiang R; Ling Y; Yao Q; Chen W Drug Resist Updat; 2023 Mar; 67():100930. PubMed ID: 36736043 [TBL] [Abstract][Full Text] [Related]
14. The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1-STAT3 signaling pathway. Lin Q; Ren L; Jian M; Xu P; Li J; Zheng P; Feng Q; Yang L; Ji M; Wei Y; Xu J Cell Death Dis; 2019 Sep; 10(10):693. PubMed ID: 31534132 [TBL] [Abstract][Full Text] [Related]
15. Tenacissoside G synergistically potentiates inhibitory effects of 5-fluorouracil to human colorectal cancer. Wang K; Liu W; Xu Q; Gu C; Hu D Phytomedicine; 2021 Jun; 86():153553. PubMed ID: 33906076 [TBL] [Abstract][Full Text] [Related]
17. Microbial metabolite sodium butyrate enhances the anti-tumor efficacy of 5-fluorouracil against colorectal cancer by modulating PINK1/Parkin signaling and intestinal flora. Li Y; He P; Chen Y; Hu J; Deng B; Liu C; Yu B; Dong W Sci Rep; 2024 Jun; 14(1):13063. PubMed ID: 38844824 [TBL] [Abstract][Full Text] [Related]
18. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer. Yan L; Yu HH; Liu YS; Wang YS; Zhao WH Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555 [TBL] [Abstract][Full Text] [Related]
19. Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation. Kong L; Wang X; Zhang K; Yuan W; Yang Q; Fan J; Wang P; Liu Q PLoS One; 2015; 10(9):e0137888. PubMed ID: 26368019 [TBL] [Abstract][Full Text] [Related]
20. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells. Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]